Company intelligence / Profile preview

Second Heart Assist

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

Second Heart Assist is developing catheter-based and wireless aortic stent pump devices for acute and chronic heart failure support. Pre-clinical studies (animal models, computational simulations) indicate high flow rates (>7 L/min) and potential benefits for acute and chronic heart failure complicated by renal dysfunction. No human clinical trial results published as of October 2025.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Second Heart Assist.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Second Heart Assist.

Explore the full profile